{"DataElement":{"publicId":"7347867","version":"1","preferredName":"Medical History Reported Term","preferredDefinition":"The reported or pre-specified name of the medical condition or event as defined by the sponsor.","longName":"MHTERM_SPD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"6421027","version":"1","preferredName":"Medical History Domain Medical History Reported Term","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history._The verbatim description of the medical history being reported.","longName":"6401571v1.0:6421025v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6401571","version":"1","preferredName":"Medical History Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history.","longName":"C49603","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medical History Domain","conceptCode":"C49603","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to subject medical history.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"738FDBAB-92FD-1DB7-E053-F662850A27F3","latestVersionIndicator":"Yes","beginDate":"2018-08-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-16","modifiedBy":"ONEDATA","dateModified":"2018-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6421025","version":"1","preferredName":"Medical History Reported Term","preferredDefinition":"The verbatim description of the medical history being reported.","longName":"C83118","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medical History Reported Term","conceptCode":"C83118","definition":"The verbatim description of the medical history being reported.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"746EB89F-9BC4-4149-E053-F662850A0793","latestVersionIndicator":"Yes","beginDate":"2018-08-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-08-27","modifiedBy":"ONEDATA","dateModified":"2018-08-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"746EB89F-9BD5-4149-E053-F662850A0793","latestVersionIndicator":"Yes","beginDate":"2018-08-27","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-08-27","modifiedBy":"TAYLORT","dateModified":"2020-02-24","changeDescription":"2/24/20 tmt released. Created as part of the CDISC mapping task_ghd_08.27.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7347851","version":"1","preferredName":"Medical History Reported Term Clinical Study Sponsor Defined Name","preferredDefinition":"The verbatim description of the medical history being reported._An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]_Clearly characterized or delimited._The words or language units by which a thing is known.","longName":"MHTERM_SPD","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"STROKE","valueDescription":"Cerebrovascular Accident","ValueMeaning":{"publicId":"4733294","version":"1","preferredName":"Cerebrovascular Accident","longName":"4733294","preferredDefinition":"A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stroke","conceptCode":"C3390","definition":"A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107BC70C-A141-B0D0-E050-BB89AD432FE8","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A96A2A45-FD92-7FB6-E053-4EBD850A2483","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"RENAL DISEASE NOS","valueDescription":"Kidney Disorder Not Otherwise Specified","ValueMeaning":{"publicId":"7347861","version":"1","preferredName":"Kidney Disorder Not Otherwise Specified","longName":"7347861","preferredDefinition":"A neoplastic or non-neoplastic condition affecting the kidney. Representative examples of non-neoplastic conditions include glomerulonephritis and nephrotic syndrome. Representative examples of neoplastic conditions include benign processes (e.g., renal lipoma and renal fibroma) and malignant processes (e.g., renal cell carcinoma and renal lymphoma).: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kidney Disorder","conceptCode":"C3149","definition":"A neoplastic or non-neoplastic condition affecting the kidney. Representative examples of non-neoplastic conditions include glomerulonephritis and nephrotic syndrome. Representative examples of neoplastic conditions include benign processes (e.g., renal lipoma and renal fibroma) and malignant processes (e.g., renal cell carcinoma and renal lymphoma).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A96A2A45-FDA0-7FB6-E053-4EBD850A2483","latestVersionIndicator":"Yes","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A96A2A45-FDBB-7FB6-E053-4EBD850A2483","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"RADIATION PNEUMONITIS","valueDescription":"Radiation-Induced Pneumonitis","ValueMeaning":{"publicId":"7347863","version":"1","preferredName":"Radiation-Induced Pneumonitis","longName":"7347863","preferredDefinition":"Pneumonitis that is associated with irradiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation-Induced Pneumonitis","conceptCode":"C27932","definition":"Pneumonitis that is associated with irradiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A96A2A45-FDC8-7FB6-E053-4EBD850A2483","latestVersionIndicator":"Yes","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A96A2A45-FDE3-7FB6-E053-4EBD850A2483","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"PULMONARY EMBOLISM","valueDescription":"Pulmonary Embolism","ValueMeaning":{"publicId":"4395768","version":"1","preferredName":"Pulmonary Embolism","longName":"4395768","preferredDefinition":"The obstruction of the pulmonary artery or one of its branches by an embolus, sometimes associated with infarction of the lung.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary Embolism","conceptCode":"C50713","definition":"The obstruction of the pulmonary artery or one of its branches by an embolus, sometimes associated with infarction of the lung.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D8E1-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A96A2A45-FDF7-7FB6-E053-4EBD850A2483","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"PULMONARY DISEASE NOS","valueDescription":"Lung Disorder Not Otherwise Specified","ValueMeaning":{"publicId":"7347864","version":"1","preferredName":"Lung Disorder Not Otherwise Specified","longName":"7347864","preferredDefinition":"A non-neoplastic or neoplastic disorder affecting the lung. Representative examples of non-neoplastic disorders include chronic obstructive pulmonary disease and pneumonia. Representative examples of neoplastic disorders include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung).: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Disorder","conceptCode":"C3198","definition":"A non-neoplastic or neoplastic disorder affecting the lung. Representative examples of non-neoplastic disorders include chronic obstructive pulmonary disease and pneumonia. Representative examples of neoplastic disorders include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A96A2A45-FE05-7FB6-E053-4EBD850A2483","latestVersionIndicator":"Yes","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A96A2A45-FE20-7FB6-E053-4EBD850A2483","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"PERIPHERAL VASCULAR DISEASE","valueDescription":"Peripheral Vascular Disorder","ValueMeaning":{"publicId":"4395396","version":"1","preferredName":"Peripheral Vascular Disorder","longName":"4395396","preferredDefinition":"Any disorder affecting blood flow through the veins or arteries outside of the heart.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peripheral Vascular Disorder","conceptCode":"C35136","definition":"Any disorder affecting blood flow through the veins or arteries outside of the heart.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB6B12D-7EE6-54C8-E040-BB89AD433F90","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A96A2A45-FE36-7FB6-E053-4EBD850A2483","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"NEUROLOGICAL DISEASE","valueDescription":"Nervous System Disorder","ValueMeaning":{"publicId":"2578551","version":"1","preferredName":"Nervous System Disorder","longName":"2578551","preferredDefinition":"Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nervous System Disorder","conceptCode":"C26835","definition":"A non-neoplastic or neoplastic disorder that affects the brain, spinal cord, or peripheral nerves.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FFE4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-05","modifiedBy":"HARTLEYG","dateModified":"2019-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A96A2A45-FE4C-7FB6-E053-4EBD850A2483","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"LIVER DISEASE NOS","valueDescription":"Hepatobiliary Disorder Not Otherwise Specified","ValueMeaning":{"publicId":"7347865","version":"1","preferredName":"Hepatobiliary Disorder Not Otherwise Specified","longName":"7347865","preferredDefinition":"A non-neoplastic or neoplastic disorder that affects the liver, bile ducts, and gallbladder. Representative examples of non-neoplastic disorders include hepatitis, cirrhosis, cholangitis, and cholecystitis. Representative examples of neoplastic disorders include hepatocellular adenoma, hepatocellular carcinoma, and cholangiocarcinoma.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatobiliary Disorder","conceptCode":"C3959","definition":"A non-neoplastic or neoplastic disorder that affects the liver, bile ducts, and gallbladder. Representative examples of non-neoplastic disorders include hepatitis, cirrhosis, cholangitis, and cholecystitis. Representative examples of neoplastic disorders include hepatocellular adenoma, hepatocellular carcinoma, and cholangiocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A96A2A45-FE59-7FB6-E053-4EBD850A2483","latestVersionIndicator":"Yes","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A96A2A45-FE74-7FB6-E053-4EBD850A2483","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"HYPERTENSION","valueDescription":"Hypertension","ValueMeaning":{"publicId":"2562555","version":"1","preferredName":"Hypertension","longName":"2562555","preferredDefinition":"Abnormally high blood pressure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypertension","conceptCode":"C3117","definition":"Blood pressure that is abnormally high.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C168-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-04","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-10-04","modifiedBy":"ZHANGW","dateModified":"2008-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A96A2A45-FE8A-7FB6-E053-4EBD850A2483","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"OBSTRUCTIVE SLEEP APNEA","valueDescription":"Obstructive Sleep Apnea","ValueMeaning":{"publicId":"6606718","version":"1","preferredName":"Obstructive Sleep Apnea","longName":"6606718","preferredDefinition":"Cessation of air flow during sleep due to upper airway obstruction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Obstructive Sleep Apnea","conceptCode":"C116337","definition":"Cessation of air flow during sleep due to upper airway obstruction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7EF40B93-B83C-48E3-E053-F662850A9D71","latestVersionIndicator":"Yes","beginDate":"2019-01-08","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-01-08","modifiedBy":"ONEDATA","dateModified":"2019-01-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A96A2A45-FEA0-7FB6-E053-4EBD850A2483","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"IMMUNE CHECKPOINT INHIBITOR (ICI) PNEUMONITIS","valueDescription":"Immune Checkpoint Inhibitor Pneumonitis","ValueMeaning":{"publicId":"7347866","version":"1","preferredName":"Immune Checkpoint Inhibitor Pneumonitis","longName":"7347866","preferredDefinition":"An agent that inhibits any of the immune checkpoint inhibitory proteins.: An inflammatory process affecting the lung parenchyma. It is a milder form of lung inflammation compared to pneumonia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune Checkpoint Inhibitor","conceptCode":"C143250","definition":"An agent that inhibits any of the immune checkpoint inhibitory proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pneumonitis","conceptCode":"C113159","definition":"An inflammatory process affecting the lung parenchyma. It is a milder form of lung inflammation compared to pneumonia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A96A2A45-FEAE-7FB6-E053-4EBD850A2483","latestVersionIndicator":"Yes","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A96A2A45-FEC9-7FB6-E053-4EBD850A2483","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"VIRAL NOS","valueDescription":"Viral Infection Not Otherwise Specified","ValueMeaning":{"publicId":"7350458","version":"1","preferredName":"Viral Infection Not Otherwise Specified","longName":"7350458","preferredDefinition":"Any disease caused by a virus.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Viral Infection","conceptCode":"C3439","definition":"Any disease caused by a virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9FB1772-4761-1533-E053-4EBD850AEF85","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-09","modifiedBy":"ONEDATA","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA58FBF6-0E19-1E27-E053-4EBD850AE076","beginDate":"2020-07-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"UNKNOWN","valueDescription":"Unknown","ValueMeaning":{"publicId":"2960664","version":"1","preferredName":"Unknown","longName":"2960664","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78485FBD-4C65-D67B-E040-BB89AD432E0E","latestVersionIndicator":"Yes","beginDate":"2009-11-13","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-11-13","modifiedBy":"KUMMEROA","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA58FBF6-0E24-1E27-E053-4EBD850AE076","beginDate":"2020-07-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"TESTS ARE PENDING","valueDescription":"Laboratory Procedure Pending","ValueMeaning":{"publicId":"7350511","version":"1","preferredName":"Laboratory Procedure Pending","longName":"7350511","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.: Not yet decided or settled; awaiting conclusion or confirmation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pending","conceptCode":"C53470","definition":"Not yet decided or settled; awaiting conclusion or confirmation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA0581C9-3E5B-4F51-E053-4EBD850AB519","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-09","modifiedBy":"ONEDATA","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA58FBF6-0E2E-1E27-E053-4EBD850AE076","beginDate":"2020-07-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"RHINOVIRUS","valueDescription":"Rhinovirus","ValueMeaning":{"publicId":"2961281","version":"1","preferredName":"Rhinovirus","longName":"2961281","preferredDefinition":"A genus of single-stranded positive sense RNA viruses containing a single RNA molecule. The viral particles are not enveloped and are icosahedral in structure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rhinovirus","conceptCode":"C77200","definition":"A genus of single-stranded positive sense RNA viruses containing a single RNA molecule. The viral particles are not enveloped and are icosahedral in structure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7898E342-FD1F-AA47-E040-BB89AD4339AD","latestVersionIndicator":"Yes","beginDate":"2009-11-17","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-11-17","modifiedBy":"ONEDATA","dateModified":"2009-11-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA58FBF6-0E39-1E27-E053-4EBD850AE076","beginDate":"2020-07-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"RECTUS SHEATH HEMATOMA","valueDescription":"Rectus Sheath Hematoma","ValueMeaning":{"publicId":"7350515","version":"1","preferredName":"Rectus Sheath Hematoma","longName":"7350515","preferredDefinition":"A collection of blood in the rectus sheath due to disruption of the superior or inferior epigastric arteries, which may present following direct trauma to the rectus abdominis muscle or anticoagulation therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rectus Sheath Hematoma","conceptCode":"C173513","definition":"A collection of blood in the rectus sheath due to disruption of the superior or inferior epigastric arteries, which may present following direct trauma to the rectus abdominis muscle or anticoagulation therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA0581C9-3EFA-4F51-E053-4EBD850AB519","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-09","modifiedBy":"ONEDATA","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA58FBF6-0E44-1E27-E053-4EBD850AE076","beginDate":"2020-07-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"PNEUMOCCAL PNEUMONIA","valueDescription":"Pneumococcal Pneumonia","ValueMeaning":{"publicId":"7049964","version":"1","preferredName":"Pneumococcal Pneumonia","longName":"7049964","preferredDefinition":"Pneumonia that is attributed to the bacteria Streptococcus pneumonia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pneumococcal Pneumonia","conceptCode":"C157959","definition":"Pneumonia that is attributed to the bacteria Streptococcus pneumonia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D60E73-173B-16B3-E053-F662850AECB5","latestVersionIndicator":"Yes","beginDate":"2019-11-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-08","modifiedBy":"ONEDATA","dateModified":"2019-11-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA58FBF6-0E4F-1E27-E053-4EBD850AE076","beginDate":"2020-07-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"OTHER","valueDescription":"Other","ValueMeaning":{"publicId":"3126125","version":"1","preferredName":"Other","longName":"3126125","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D01180C-814A-B8B4-E040-BB89AD432507","latestVersionIndicator":"Yes","beginDate":"2010-08-04","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-08-04","modifiedBy":"KUMMEROA","dateModified":"2023-03-07","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":"2023.3.7 Alt VM added per ticket request CADSR0002119. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA58FBF6-0E5A-1E27-E053-4EBD850AE076","beginDate":"2020-07-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"ORDINARY CORONAVIRUS","valueDescription":"Coronavirus","ValueMeaning":{"publicId":"3767194","version":"1","preferredName":"Coronavirus","longName":"3767194","preferredDefinition":"A genus of single-stranded, positive-sense RNA viruses in the family coronaviridae. The coronavirus genome exhibits helical symmetry.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Coronavirus","conceptCode":"C26431","definition":"A genus of single-stranded, positive-sense RNA viruses in the family coronaviridae. The coronavirus genome exhibits helical symmetry.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DD33D016-5942-8C70-E040-BB89AD432AB2","latestVersionIndicator":"Yes","beginDate":"2013-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA58FBF6-0E64-1E27-E053-4EBD850AE076","beginDate":"2020-07-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"NO OTHER INFECTION DIAGNOSED","valueDescription":"Negation Other Infectious Disorder Diagnosis","ValueMeaning":{"publicId":"7350419","version":"1","preferredName":"Negation Other Infectious Disorder Diagnosis","longName":"7350419","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Different than the one(s) previously specified or mentioned.: A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.: The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA03A16F-2086-584A-E053-4EBD850A4C28","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-09","modifiedBy":"ONEDATA","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA58FBF6-0E6F-1E27-E053-4EBD850AE076","beginDate":"2020-07-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"INFLUENZA B","valueDescription":"Influenza B Virus","ValueMeaning":{"publicId":"2934602","version":"1","preferredName":"Influenza B Virus","longName":"2934602","preferredDefinition":"A negative-strand linear single-strand RNA virus with an 8 segment genome. Virions are enveloped and usually spherical or pleomorphic, 50-120 nm in diameter. Influenza B viruses are usually found only in humans. Unlike influenza A viruses, these viruses are not classified according to subtype.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Influenza B Virus","conceptCode":"C53468","definition":"A negative-strand linear single-strand RNA virus with an 8 segment genome. Virions are enveloped and usually spherical or pleomorphic, 50-120 nm in diameter. Influenza B viruses are usually found only in humans. Unlike influenza A viruses, these viruses are not classified according to subtype.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71855E80-BA45-E674-E040-BB89AD437920","latestVersionIndicator":"Yes","beginDate":"2009-08-19","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-08-19","modifiedBy":"ONEDATA_WA","dateModified":"2023-06-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA58FBF6-0E7A-1E27-E053-4EBD850AE076","beginDate":"2020-07-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"INFLUENZA A","valueDescription":"Influenza A Virus","ValueMeaning":{"publicId":"2934600","version":"1","preferredName":"Influenza A Virus","longName":"2934600","preferredDefinition":"A negative-strand linear single-strand RNA virus with an 8 segment genome. Virions are enveloped and usually spherical or pleomorphic, 80-120 nm in diameter. Subtyping is based on the antigenic properties of the hemagglutinin and neuraminidase proteins. Influenza type A viruses can infect people, birds, pigs, horses, and other animals, but wild birds are the natural hosts for these viruses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Influenza A Virus","conceptCode":"C53454","definition":"A negative-strand linear single-strand RNA virus with an 8 segment genome. Virions are enveloped and usually spherical or pleomorphic, 80-120 nm in diameter. Subtyping is based on the antigenic properties of the hemagglutinin and neuraminidase proteins. Influenza type A viruses can infect people, birds, pigs, horses, and other animals, but wild birds are the natural hosts for these viruses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71855E80-BA1F-E674-E040-BB89AD437920","latestVersionIndicator":"Yes","beginDate":"2009-08-19","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-08-19","modifiedBy":"ONEDATA_WA","dateModified":"2023-06-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA58FBF6-0E85-1E27-E053-4EBD850AE076","beginDate":"2020-07-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"GRAM POSITIVE BACTERIA NOS","valueDescription":"Gram Positive Bacteria Not Otherwise Specified","ValueMeaning":{"publicId":"7350514","version":"1","preferredName":"Gram Positive Bacteria Not Otherwise Specified","longName":"7350514","preferredDefinition":"Any bacteria with a thick peptidoglycan layer and no outer lipid membrane that stains dark purple with the Gram staining technique.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gram Positive Bacteria","conceptCode":"C173515","definition":"Any bacteria with a thick peptidoglycan layer and no outer lipid membrane that stains dark purple with the Gram staining technique.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA0581C9-3ED3-4F51-E053-4EBD850AB519","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-09","modifiedBy":"ONEDATA","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA58FBF6-0E8F-1E27-E053-4EBD850AE076","beginDate":"2020-07-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"GRAM NEGATIVE BACTERIA NOS","valueDescription":"Gram Negative Bacteria Not Otherwise Specified","ValueMeaning":{"publicId":"7350513","version":"1","preferredName":"Gram Negative Bacteria Not Otherwise Specified","longName":"7350513","preferredDefinition":"Any bacteria with a thin peptidoglycan layer and an outer lipid membrane that stains pink with the Gram staining technique.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gram Negative Bacteria","conceptCode":"C173514","definition":"Any bacteria with a thin peptidoglycan layer and an outer lipid membrane that stains pink with the Gram staining technique.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA0581C9-3EAB-4F51-E053-4EBD850AB519","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-09","modifiedBy":"ONEDATA","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA58FBF6-0E9A-1E27-E053-4EBD850AE076","beginDate":"2020-07-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"FUNGAL NOS","valueDescription":"Fungal Infection Not Otherwise Specified","ValueMeaning":{"publicId":"7350512","version":"1","preferredName":"Fungal Infection Not Otherwise Specified","longName":"7350512","preferredDefinition":"An infection caused by a fungus.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fungal Infection","conceptCode":"C3245","definition":"An infection caused by a fungus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA0581C9-3E83-4F51-E053-4EBD850AB519","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-09","modifiedBy":"ONEDATA","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA58FBF6-0EA5-1E27-E053-4EBD850AE076","beginDate":"2020-07-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"BACTERIAL INFECTION NOS","valueDescription":"Bacterial Infection Not Otherwise Specified","ValueMeaning":{"publicId":"7350467","version":"1","preferredName":"Bacterial Infection Not Otherwise Specified","longName":"7350467","preferredDefinition":"An acute infectious disorder that is caused by gram positive or gram negative bacteria; representative examples include pneumococcal, streptococcal, salmonella, and meningeal infections.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bacterial Infection","conceptCode":"C2890","definition":"An acute infectious disorder that is caused by gram positive or gram negative bacteria; representative examples include pneumococcal, streptococcal, salmonella, and meningeal infections.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA039436-6ECF-4FF0-E053-4EBD850A9B49","latestVersionIndicator":"Yes","beginDate":"2020-07-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-09","modifiedBy":"ONEDATA","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA58FBF6-0EB0-1E27-E053-4EBD850AE076","beginDate":"2020-07-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"ESRD ON DIALYSIS","valueDescription":"End Stage Renal Disease With Dialysis","ValueMeaning":{"publicId":"7347857","version":"1","preferredName":"End Stage Renal Disease With Dialysis","longName":"7347857","preferredDefinition":"Long-standing and persistent renal disease with glomerular filtration rate (GFR) less than 15 ml/min.: Used to indicate the presence of something or someone.: A procedure to remove toxic substances from the blood that is used in patients with end-stage chronic kidney disease or acute kidney failure. This includes hemodialysis and peritoneal dialysis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Kidney Disease, Stage 5","conceptCode":"C9439","definition":"Long-standing and persistent renal disease with glomerular filtration rate (GFR) less than 15 ml/min.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dialysis","conceptCode":"C15221","definition":"A procedure to remove toxic substances from the blood that is used in patients with end-stage chronic kidney disease or acute kidney failure. This includes hemodialysis and peritoneal dialysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9795F59-2881-7362-E053-4EBD850ACF89","latestVersionIndicator":"Yes","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"TAYLORT","dateModified":"2020-07-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9795F59-289C-7362-E053-4EBD850ACF89","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"DEMENTIA","valueDescription":"Dementia","ValueMeaning":{"publicId":"3165569","version":"1","preferredName":"Dementia","longName":"3165569","preferredDefinition":"An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dementia","conceptCode":"C4786","definition":"Loss of intellectual abilities interfering with an individual's social and occupational functions. Causes include Alzheimer's disease, brain injuries, brain tumors, and vascular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96FCF74F-C196-EAB7-E040-BB89AD437850","latestVersionIndicator":"Yes","beginDate":"2010-12-09","endDate":null,"createdBy":"LUY","dateCreated":"2010-12-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9794A11-5875-7463-E053-4EBD850A2344","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"CORONARY ARTERY DISEASE/MYOCARDIAL INFARCTION","valueDescription":"Coronary Artery Disease Myocardial Infarction","ValueMeaning":{"publicId":"7347852","version":"1","preferredName":"Coronary Artery Disease Myocardial Infarction","longName":"7347852","preferredDefinition":"An imbalance between myocardial functional requirements and the capacity of the coronary vessels to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.: Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area, as in coronary thrombosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Coronary Artery Disease","conceptCode":"C26732","definition":"Narrowing of the coronary arteries due to fatty deposits inside the arterial walls. The diagnostic criteria may include documented history of any of the following: documented coronary artery stenosis greater than or equal to 50% (by cardiac catheterization or other modality of direct imaging of the coronary arteries); previous coronary artery bypass surgery (CABG); previous percutaneous coronary intervention (PCI); previous myocardial infarction. (ACC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Myocardial Infarction","conceptCode":"C27996","definition":"Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area, as in coronary thrombosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9794A11-588C-7463-E053-4EBD850A2344","latestVersionIndicator":"Yes","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9794A11-58A7-7463-E053-4EBD850A2344","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"COPD/EMPHYSEMA","valueDescription":"Chronic Obstructive Pulmonary Disease Pulmonary Emphysema","ValueMeaning":{"publicId":"7347853","version":"1","preferredName":"Chronic Obstructive Pulmonary Disease Pulmonary Emphysema","longName":"7347853","preferredDefinition":"A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.: A subcategory of chronic obstructive pulmonary disease (COPD). It occurs in people who smoke and suffer from chronic bronchitis. It is characterized by inflation of the alveoli, alveolar wall damage, and reduction in the number of alveoli, resulting in difficulty breathing.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Obstructive Pulmonary Disease","conceptCode":"C3199","definition":"A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pulmonary Emphysema","conceptCode":"C3348","definition":"A subcategory of chronic obstructive pulmonary disease (COPD). It occurs in people who smoke and suffer from chronic bronchitis. It is characterized by inflation of the alveoli, alveolar wall damage, and reduction in the number of alveoli, resulting in difficulty breathing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9794A11-58B4-7463-E053-4EBD850A2344","latestVersionIndicator":"Yes","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9794A11-58CF-7463-E053-4EBD850A2344","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"CONGESTIVE HEART FAILURE","valueDescription":"Congestive heart failure","ValueMeaning":{"publicId":"2565944","version":"1","preferredName":"Congestive heart failure","longName":"2565944","preferredDefinition":"Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Congestive Heart Failure","conceptCode":"C3080","definition":"Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CEA5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9794A11-58E5-7463-E053-4EBD850A2344","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"CIRRHOSIS","valueDescription":"Cirrhosis","ValueMeaning":{"publicId":"4618018","version":"1","preferredName":"Cirrhosis","longName":"4618018","preferredDefinition":"A chronic degenerative disease of the liver characterized by parenchymal nodularity and fibrosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cirrhosis","conceptCode":"C2951","definition":"A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09518164-CFAC-8FD3-E050-BB89AD433831","latestVersionIndicator":"Yes","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9794A11-58F9-7463-E053-4EBD850A2344","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"CHRONIC RENAL INSUFFICIENCY","valueDescription":"Chronic Kidney Disease","ValueMeaning":{"publicId":"2944301","version":"1","preferredName":"Chronic Kidney Disease","longName":"2944301","preferredDefinition":"Gradual and usually permanent loss of kidney function resulting in renal failure. Causes include diabetes, hypertension, and glomerulonephritis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Kidney Disease","conceptCode":"C80078","definition":"Impairment of the renal function secondary to chronic kidney damage persisting for three or more months.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74301D2A-4EFE-F34C-E040-BB89AD430317","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9794A11-590F-7463-E053-4EBD850A2344","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"CARDIAC DISEASE NOS","valueDescription":"Cardiovascular Disorder Not Otherwise Specified","ValueMeaning":{"publicId":"7347854","version":"1","preferredName":"Cardiovascular Disorder Not Otherwise Specified","longName":"7347854","preferredDefinition":"A non-neoplastic or neoplastic disorder affecting the heart or the vessels (arteries, veins and lymph vessels). Representative examples of non-neoplastic cardiovascular disorders are endocarditis and hypertension. Representative examples of neoplastic cardiovascular disorders are endocardial myxoma and angiosarcoma.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cardiovascular Disorder","conceptCode":"C2931","definition":"A non-neoplastic or neoplastic disorder affecting the heart or the vessels (arteries, veins and lymph vessels). Representative examples of non-neoplastic cardiovascular disorders are endocarditis and hypertension. Representative examples of neoplastic cardiovascular disorders are endocardial myxoma and angiosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9794A11-591D-7463-E053-4EBD850A2344","latestVersionIndicator":"Yes","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9794A11-5938-7463-E053-4EBD850A2344","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"CARDIAC ARRHYTHMIA NOS","valueDescription":"Arrhythmia Not Otherwise Specified","ValueMeaning":{"publicId":"7347855","version":"1","preferredName":"Arrhythmia Not Otherwise Specified","longName":"7347855","preferredDefinition":"Any variation from the normal rate or rhythm (which may include the origin of the impulse and/or its subsequent propagation) in the heart.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arrhythmia","conceptCode":"C2881","definition":"Any variation from the normal rate or rhythm (which may include the origin of the impulse and/or its subsequent propagation) in the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9794A11-5945-7463-E053-4EBD850A2344","latestVersionIndicator":"Yes","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9794A11-5960-7463-E053-4EBD850A2344","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"ATRIAL FIBRILLATION","valueDescription":"Atrial Fibrillation","ValueMeaning":{"publicId":"2760267","version":"1","preferredName":"Atrial Fibrillation","longName":"2760267","preferredDefinition":"A supraventricular arrhythmia characterized by uncoordinated atrial myocardium activation due to multiple reentry circuits with consequent deterioration of atrial mechanical function. Instead of intermittently contracting, the atria quiver continuously in a chaotic pattern, causing a totally irregular, often tachycardia ventricular rate. On the ECG it is described by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape, and timing, associated with an irregular, frequently rapid ventricular response when atrioventricular conduction is intact.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atrial Fibrillation","conceptCode":"C50466","definition":"A disorder characterized by an electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregular ventricular response. (CDISC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FF5CBC6-3C42-1060-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-06-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9794A11-5974-7463-E053-4EBD850A2344","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"ASTHMA","valueDescription":"Asthma","ValueMeaning":{"publicId":"2975594","version":"1","preferredName":"Asthma","longName":"2975594","preferredDefinition":"A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Asthma","conceptCode":"C28397","definition":"A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C08420A-B206-2A47-E040-BB89AD433D97","latestVersionIndicator":"Yes","beginDate":"2009-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9794A11-598B-7463-E053-4EBD850A2344","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"ESRD NOT ON DIALYSIS","valueDescription":"End Stage Renal Disease Without Dialysis","ValueMeaning":{"publicId":"7347856","version":"1","preferredName":"End Stage Renal Disease Without Dialysis","longName":"7347856","preferredDefinition":"Long-standing and persistent renal disease with glomerular filtration rate (GFR) less than 15 ml/min.: Used to indicate the absence or lack of something or someone.: A procedure to remove toxic substances from the blood that is used in patients with end-stage chronic kidney disease or acute kidney failure. This includes hemodialysis and peritoneal dialysis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Kidney Disease, Stage 5","conceptCode":"C9439","definition":"Long-standing and persistent renal disease with glomerular filtration rate (GFR) less than 15 ml/min.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Without","conceptCode":"C25718","definition":"Used to indicate the absence or lack of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dialysis","conceptCode":"C15221","definition":"A procedure to remove toxic substances from the blood that is used in patients with end-stage chronic kidney disease or acute kidney failure. This includes hemodialysis and peritoneal dialysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9780878-0386-3450-E053-4EBD850AB49C","latestVersionIndicator":"Yes","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"TAYLORT","dateModified":"2020-07-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9780878-039F-3450-E053-4EBD850AB49C","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7181428","version":"1","preferredName":"Medical History Reported Term Clinical Study Sponsor Defined Name","preferredDefinition":"The verbatim description of the medical history being reported.:An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]:Clearly characterized or delimited.:The words or language units by which a thing is known.","longName":"C83118:C70793:C165683:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medical History Reported Term","conceptCode":"C83118","definition":"The verbatim description of the medical history being reported.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical Study Sponsor","conceptCode":"C70793","definition":"An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Defined","conceptCode":"C165683","definition":"Clearly characterized or delimited.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F16CCF2-3E62-2F41-E053-F662850A677B","latestVersionIndicator":"Yes","beginDate":"2020-02-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-21","modifiedBy":"ONEDATA","dateModified":"2020-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9794A11-5856-7463-E053-4EBD850A2344","latestVersionIndicator":"Yes","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"SOKKERL","dateModified":"2022-06-13","changeDescription":"7-2-20 NCICOVID; TMT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Theradex - 2","type":"Alternate Question Text","description":"Provide co-infection","url":null,"context":"Theradex"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"If yes, check all that apply:","url":null,"context":"Theradex"},{"name":"What is the medical condition","type":"Preferred Question Text","description":"What is the medical condition or event term?","url":null,"context":"Theradex"},{"name":"Theradex - 3","type":"Alternate Question Text","description":"Check all that apply","url":null,"context":"Theradex"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A979A2D6-22E9-30E1-E053-4EBD850AF6E7","latestVersionIndicator":"Yes","beginDate":"2020-07-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-07-02","modifiedBy":"SOKKERL","dateModified":"2020-09-03","changeDescription":"7-2-20 NCICOVID; TMT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}